Source: Toxicology and Applied Pharmacology. Unidades: ICB, FM
Subjects: FARMACOLOGIA, LEUCEMIA, LINFOMA, APOPTOSE, ANTINEOPLÁSICOS, MEDULA ÓSSEA DE ANIMAL, CAMUNDONGOS
ABNT
ANTONIOLLI, Giorgio et al. In Silico, in vitro, and in vivo studies of a 2-substituted quinazolin-4(3H)-one in T-cell acute lymphoblastic leukemia. Toxicology and Applied Pharmacology, v. 507, 2026Tradução . . Disponível em: https://doi.org/10.1016/j.taap.2025.117667. Acesso em: 05 abr. 2026.APA
Antoniolli, G., Franchi Junior, G. C., Lima, K., Lopes, R. de M., Barbosa, E. G., Machado Neto, J. A., et al. (2026). In Silico, in vitro, and in vivo studies of a 2-substituted quinazolin-4(3H)-one in T-cell acute lymphoblastic leukemia. Toxicology and Applied Pharmacology, 507. doi:10.1016/j.taap.2025.117667NLM
Antoniolli G, Franchi Junior GC, Lima K, Lopes R de M, Barbosa EG, Machado Neto JA, Lima CSP, Rodrigues T, Coelho F. In Silico, in vitro, and in vivo studies of a 2-substituted quinazolin-4(3H)-one in T-cell acute lymphoblastic leukemia [Internet]. Toxicology and Applied Pharmacology. 2026 ; 507[citado 2026 abr. 05 ] Available from: https://doi.org/10.1016/j.taap.2025.117667Vancouver
Antoniolli G, Franchi Junior GC, Lima K, Lopes R de M, Barbosa EG, Machado Neto JA, Lima CSP, Rodrigues T, Coelho F. In Silico, in vitro, and in vivo studies of a 2-substituted quinazolin-4(3H)-one in T-cell acute lymphoblastic leukemia [Internet]. Toxicology and Applied Pharmacology. 2026 ; 507[citado 2026 abr. 05 ] Available from: https://doi.org/10.1016/j.taap.2025.117667
